BIOLASE, INC Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Biolase, Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Biolase, Inc Return On Equity for the quarter ending September 30, 2024 was 547 %.
  • Biolase, Inc annual Return On Equity for 2023 was -555 %, a 196% decline from 2022.
  • Biolase, Inc annual Return On Equity for 2022 was -188 %, a 256% decline from 2021.
  • Biolase, Inc annual Return On Equity for 2021 was -52.9 %, a 84% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 547 +1.05K Jul 1, 2024 Sep 30, 2024
Q2 2024 1.24K +1.59K Apr 1, 2024 Jun 30, 2024
Q1 2024 -1.78K -1.54K -628% Jan 1, 2024 Mar 31, 2024
Q4 2023 -555 -367 -196% Oct 1, 2023 Dec 31, 2023
Q3 2023 -503 -385 -325% Jul 1, 2023 Sep 30, 2023
Q2 2023 -346 -268 -346% Apr 1, 2023 Jun 30, 2023
Q1 2023 -245 -194 -377% Jan 1, 2023 Mar 31, 2023
Q4 2022 -188 -135 -256% Oct 1, 2022 Dec 31, 2022
Q3 2022 -118 -54.8 -86.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -77.5 -16.9 -28% Apr 1, 2022 Jun 30, 2022
Q1 2022 -51.3 +69.5 +57.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -52.9 +278 +84% Oct 1, 2021 Dec 31, 2021
Q3 2021 -63.5 +471 +88.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -60.6 -1.93K -103% Apr 1, 2021 Jun 30, 2021
Q1 2021 -121 -4.47K -103% Jan 1, 2021 Mar 31, 2021
Q4 2020 -331 +377 +53.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -534 -127 -31.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 1.87K +2.08K Apr 1, 2020 Jun 30, 2020
Q1 2020 4.35K +4.5K Jan 1, 2020 Mar 31, 2020
Q4 2019 -708 -590 -499% Oct 1, 2019 Dec 31, 2019
Q3 2019 -408 -327 -403% Jul 1, 2019 Sep 30, 2019
Q2 2019 -213 -137 -178% Apr 1, 2019 Jun 30, 2019
Q1 2019 -156 -85.6 -121% Jan 1, 2019 Mar 31, 2019
Q4 2018 -118 -46.7 -65.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -81.1 -0.86 -1.07% Jul 1, 2018 Sep 30, 2018
Q2 2018 -76.8 -7.22 -10.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 -70.6 +0.64 +0.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -71.6 -2.29 -3.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -80.3 -21.7 -37% Jul 1, 2017 Sep 30, 2017
Q2 2017 -69.6 -1.63 -2.4% Apr 1, 2017 Jun 30, 2017
Q1 2017 -71.2 +2.32 +3.15% Jan 1, 2017 Mar 31, 2017
Q4 2016 -69.3 -1.44 -2.12% Oct 1, 2016 Dec 31, 2016
Q3 2016 -58.6 +5.64 +8.78% Jul 1, 2016 Sep 30, 2016
Q2 2016 -68 -1.77 -2.67% Apr 1, 2016 Jun 30, 2016
Q1 2016 -73.6 +10.1 +12% Jan 1, 2016 Mar 31, 2016
Q4 2015 -67.9 +48.5 +41.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 -64.2 +152 +70.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 -66.2 +169 +71.9% Apr 1, 2015 Jun 30, 2015
Q1 2015 -83.6 +72.7 +46.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -116 +11.9 +9.24% Oct 1, 2014 Dec 31, 2014
Q3 2014 -217 -133 -158% Jul 1, 2014 Sep 30, 2014
Q2 2014 -236 -189 -400% Apr 1, 2014 Jun 30, 2014
Q1 2014 -156 -118 -313% Jan 1, 2014 Mar 31, 2014
Q4 2013 -128 -101 -368% Oct 1, 2013 Dec 31, 2013
Q3 2013 -83.9 -29.9 -55.4% Jul 1, 2013 Sep 30, 2013
Q2 2013 -47.1 +5.82 +11% Apr 1, 2013 Jun 30, 2013
Q1 2013 -37.9 +2.42 +6% Jan 1, 2013 Mar 31, 2013
Q4 2012 -27.4 Oct 1, 2012 Dec 31, 2012
Q3 2012 -54 Jul 1, 2012 Sep 30, 2012
Q2 2012 -52.9 Apr 1, 2012 Jun 30, 2012
Q1 2012 -40.3 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.